(CIDRAP News) – The US Department of Health and Human Services (HHS) has accepted the first batch of H5N1 avian influenza vaccine based on the H5N1 variant known as clade 2.2, which has spread most widely across Asia, Europe, and Africa.
(CIDRAP News) Researchers recently reported identifying two mutations in the H5N1 avian influenza virus that seem to improve its ability to attach to human cells, a finding that may help scientists spot H5N1 strains capable of infecting humans.
(CIDRAP News) As the H5N1 avian influenza virus continued to claim human victims, World Health Organization (WHO) and other experts met in Geneva today for a 3-day conference to hone the agency's pandemic response plan.
(CIDRAP News) Public health experts will meet in Geneva next week to continue developing the World Health Organization's (WHO's) draft plan for quick action to head off a potential influenza pandemic.
The WHO announced the meeting as a Hong Kong official reported another possible human case of H5N1 avian flu in China, involving a 32-year-old man who died yesterday.